Dr Gregor Lichtfuss
Gregor trained in immunology and public health, and has spent most of his career building biotechnology companies. He led venture creation for Cardior Pharmaceuticals, an RNA therapeutics company in Germany acquired by Novo Nordisk in 2024, and co-founded the Australian therapeutics company Exopharm.
Pharmaceutical manufacturing in Australia drew his interest to food, agriculture and the ocean: what the bioprocessing methods of medicine could do for how food is produced, and for the Australian economy. He founded the venture studio Blue Ocean Ventures in 2023 to pursue that idea, and launched SHRMP.bio from it in 2024.
He holds an MSc from Humboldt-Universität zu Berlin and a doctorate from Monash University, and completed Stanford Ignite and the Certificate of Business Excellence at UC Berkeley. He is the director of the biotech industry consultancy Ribosomic, and founded Aurora Sailing, through which he leads volunteer youth adventure sailing programmes.
